Quality Assessment: Strong Fundamentals but Mixed Recent Performance
Coromandel International continues to demonstrate robust long-term fundamental strength. The company boasts an average Return on Equity (ROE) of 20.41%, signalling efficient capital utilisation over time. Its net sales have grown at a healthy compound annual growth rate (CAGR) of 16.45%, underscoring consistent revenue expansion. Additionally, the firm maintains a conservative capital structure with an average debt-to-equity ratio of just 0.03 times, reflecting low leverage and financial prudence.
However, recent quarterly results have been lacklustre. The Q3 FY25-26 financials showed flat performance, with no significant growth in core earnings. Interest expenses for the nine months ended December 2025 rose sharply by 23.54% to ₹253.27 crores, while the debt-to-equity ratio at half-year stood at a relatively elevated 0.12 times, the highest in recent periods. Cash and cash equivalents also declined to ₹1,362.74 crores, the lowest recorded in the half-yearly data, raising concerns about liquidity buffers.
Despite a 28.8% increase in profits over the past year, the stock’s one-year return has been negative at -5.45%, underperforming the broader market benchmark BSE500, which delivered 5.71% returns over the same period. This divergence suggests that investors are cautious about the company’s near-term prospects despite improving earnings.
Patience pays off here! This Micro Cap from Fertilizers sector has delivered steady gains quarter after quarter. Now proudly part of our Reliable Performers list.
- - New Reliable Performer
- - Steady quarterly gains
- - Fertilizers consistency
Valuation: Premium Pricing Raises Concerns
Coromandel International’s valuation metrics have become a key factor in the downgrade. The stock trades at a Price to Book (P/B) ratio of 5.1, which is considered very expensive relative to its historical averages and peer group valuations within the fertilisers sector. This premium pricing is not fully justified by the company’s recent financial performance or growth outlook, especially given the flat quarterly results and rising interest costs.
The company’s Return on Equity of 17.5% in the latest period, while respectable, does not sufficiently support the current valuation premium. Moreover, the Price/Earnings to Growth (PEG) ratio stands at 1, indicating that the market has already priced in expected earnings growth, leaving limited upside potential. Investors may be wary of paying a high premium amid uncertain near-term earnings momentum and sector headwinds.
Financial Trend: Flat Recent Results and Rising Costs
The financial trend for Coromandel International has been largely flat in the short term. The Q3 FY25-26 results showed no meaningful growth, signalling a pause in the company’s otherwise steady expansion. Interest expenses have increased significantly by 23.54% over nine months, reflecting higher borrowing costs or increased debt utilisation. Although the debt-to-equity ratio remains low by industry standards, the recent uptick to 0.12 times is notable and warrants monitoring.
Cash reserves have also declined to ₹1,362.74 crores, the lowest in recent half-yearly data, which could constrain the company’s ability to invest aggressively or weather market volatility. These financial trends contribute to a cautious outlook, especially when combined with the stock’s premium valuation.
Technical Analysis: Shift to Bearish Momentum
The most significant trigger for the downgrade has been the deterioration in technical indicators. The technical grade has shifted from mildly bearish to outright bearish, signalling increased downside risk in the near term. Key technical metrics paint a cautious picture:
- MACD: Weekly readings are bearish, while monthly remain mildly bearish, indicating weakening momentum.
- RSI: Both weekly and monthly Relative Strength Index show no clear signal, suggesting indecision but no bullish momentum.
- Bollinger Bands: Weekly bands are bearish, with monthly bands mildly bearish, pointing to increased volatility and downward pressure.
- Moving Averages: Daily moving averages are bearish, confirming short-term negative trends.
- KST (Know Sure Thing): Weekly readings are bearish, monthly mildly bearish, reinforcing the negative momentum.
- Dow Theory and OBV: Both weekly and monthly readings show no clear trend, indicating lack of strong directional conviction.
The stock price closed at ₹2,089.80 on 16 April 2026, down marginally by 0.21% from the previous close of ₹2,094.10. It remains well below its 52-week high of ₹2,720.00, reflecting the subdued technical outlook. The stock’s one-week return was -1.22%, underperforming the Sensex’s 0.71% gain, further highlighting short-term weakness.
Market Position and Sector Context
Coromandel International remains the largest company in the fertilisers sector with a market capitalisation of ₹61,652 crores, representing 30.33% of the sector’s total market cap. Its annual sales of ₹30,464.27 crores account for 19.14% of the industry, underscoring its dominant position. Institutional investors hold a significant 30.49% stake, reflecting confidence in the company’s long-term prospects despite recent challenges.
Over the long term, the stock has delivered exceptional returns, with a 10-year gain of 851.64% compared to the Sensex’s 204.80%. The three- and five-year returns of 125.16% and 184.66% respectively also outpace the broader market, demonstrating the company’s ability to generate wealth over extended periods.
Holding Coromandel International Ltd from Fertilizers? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Conclusion: Downgrade Reflects Near-Term Risks Despite Long-Term Strength
The downgrade of Coromandel International Ltd from Hold to Sell by MarketsMOJO on 15 April 2026 is primarily driven by a shift to bearish technical trends, expensive valuation levels, and flat recent financial performance. While the company’s long-term fundamentals remain strong, with solid ROE, low leverage, and healthy sales growth, the short-term outlook is clouded by rising interest costs, declining cash reserves, and subdued earnings momentum.
Investors should weigh the premium valuation against the current technical weakness and financial trends before considering fresh exposure. The stock’s underperformance relative to the broader market over the past year further emphasises the need for caution. Those holding Coromandel International may want to explore alternative opportunities within the fertilisers sector or broader market that offer better risk-reward profiles.
Overall, the downgrade signals a prudent reassessment of the stock’s near-term prospects, balancing its dominant market position and long-term growth with emerging headwinds and technical vulnerabilities.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
